ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Diet & Nutrition Wins Ok To Use Program Grants

February 20, 1976

Proposed DRG Regulations Would Limit Exemptions To Fox Chase, M.D. Anderson; In Effect Oct. 1

September 9, 1983

Survivors With Gene Variant At More Risk For Heart Disease

June 25, 2010

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992

Sharfstein To Leave FDA

January 7, 2011

President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel

June 1, 2001